K
Koen Brusselmans
Researcher at Katholieke Universiteit Leuven
Publications - 22
Citations - 7251
Koen Brusselmans is an academic researcher from Katholieke Universiteit Leuven. The author has contributed to research in topics: Cancer cell & Cell growth. The author has an hindex of 18, co-authored 22 publications receiving 6801 citations. Previous affiliations of Koen Brusselmans include Catholic University of Leuven.
Papers
More filters
Journal ArticleDOI
Role of HIF-1alpha in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis.
Peter Carmeliet,Yuval Dor,Jean-Marc Herbert,Dai Fukumura,Koen Brusselmans,Mieke Dewerchin,Michal Neeman,Françoise Bono,Rinat Abramovitch,Patrick H. Maxwell,Cameron J. Koch,Peter J. Ratcliffe,Lieve Moons,Rakesh K. Jain,Desire Collen,Eli Keshert +15 more
TL;DR: It is shown that hypoxia and hypoglycaemia reduce proliferation and increase apoptosis in wild-type (Hif-1α+/+) embryonic stem (ES) cells, but not in ES cells with inactivated HIF-1 α genes (HIF- 1α−/−), suggesting that there are at least two different adaptive responses to being deprived of oxygen and nutrients.
Journal ArticleDOI
Impaired myocardial angiogenesis and ischemic cardiomyopathy in mice lacking the vascular endothelial growth factor isoforms VEGF164 and VEGF188.
Peter Carmeliet,Yin-Shan Ng,Dieter Nuyens,Gregor Theilmeier,Koen Brusselmans,Ivo Cornelissen,Elisabeth Ehler,Vijay V. Kakkar,Ingeborg Stalmans,Virginie Mattot,Jean Claude Perriard,Mieke Dewerchin,Willem Flameng,Andras Nagy,Florea Lupu,Lieve Moons,Desire Collen,Patricia A. D'Amore,David T. Shima +18 more
TL;DR: Impaired myocardial angiogenesis and ischemic cardiomyopathy in mice lacking the vascular endothelial growth factor isoforms V EGF 164 and VEGF 188 is observed.
Journal ArticleDOI
Loss of HIF-2α and inhibition of VEGF impair fetal lung maturation, whereas treatment with VEGF prevents fatal respiratory distress in premature mice
Veerle Compernolle,Koen Brusselmans,Till Acker,Peter Hoet,Marc Tjwa,Heike Beck,Stéphane Plaisance,Yuval Dor,Eli Keshet,Florea Lupu,Benoit Nemery,Mieke Dewerchin,Paul P. Van Veldhoven,Karl H. Plate,Lieve Moons,Desire Collen,Peter Carmeliet +16 more
TL;DR: It is reported that loss of the hypoxia-inducible transcription factor-2 α (HIF-2α) caused fatal RDS in neonatal mice due to insufficient surfactant production by alveolar type 2 cells and the pneumotrophic effect of VEGF may have therapeutic potential for lung maturation in preterm infants.
Journal ArticleDOI
De novo Lipogenesis Protects Cancer Cells from Free Radicals and Chemotherapeutics by Promoting Membrane Lipid Saturation
Evelien Rysman,Koen Brusselmans,Katryn Scheys,Leen Timmermans,Rita Derua,Sebastian Munck,Paul P. Van Veldhoven,David Waltregny,Veerle W. Daniels,Jelle Machiels,Frank Vanderhoydonc,Karine Smans,Etienne Waelkens,Guido Verhoeven,Johannes V. Swinnen +14 more
TL;DR: Evidence is provided that shifting lipid acquisition from lipid uptake toward de novo lipogenesis dramatically changes membrane properties and protects cells from both endogenous and exogenous insults, and provides a rationale for the use of lipogenesis inhibitors as antineoplastic agents and as chemotherapeutic sensitizers.
Journal ArticleDOI
Increased lipogenesis in cancer cells: new players, novel targets
TL;DR: Not only fatty acid synthase, but in fact all key enzymes involved in fatty acid synthesis as well as key metabolic regulators are potential targets for antineoplastic intervention.